Separations (Dec 2022)

Bronchodilator Secondary Metabolites from <i>Rhazya stricta</i> Decne Aerial Parts

  • Maged S. Abdel-Kader,
  • Najeeb U. Rehman,
  • Abdullah F. Aldosari,
  • Fahad S. Almutib,
  • Ali I. Al Muwinea,
  • Abdulaziz S. Saeedan

DOI
https://doi.org/10.3390/separations9120412
Journal volume & issue
Vol. 9, no. 12
p. 412

Abstract

Read online

The plant kingdom comprises medicinally useful plants that have provided many new drugs used to treat various diseases. In our search for bronchodilator secondary metabolites from plants growing in Saudi Arabia, the total extract of Rhazya stricta showed activity against carbamylcholine- (CCh) induced bronchoconstriction in guinea pig tracheal muscles used as an ex vivo model. The fractions obtained from liquid–liquid extraction process were tested for bronchodilator effects. The most active ethyl acetate fraction (RS-E) and aqueous fraction (RS-H) were subjected to biologically guided phytochemical study using different stationary phases and chromatographic techniques to isolate the pure secondary metabolites. Five known compounds were isolated from the active fractions. Three alkaloids namely; (-)-quebrachamine (1), (+)-eburenine (2), (+)-stemmadenine (3) as well as the two iridoid glycosides loganic acid (4) and loganine (5) were identified by various spectroscopic methods. Among the isolated compounds 1 and 5 were the only active as bronchodilators in the plant. It is worth to mention that iridoid glycosides are isolated for the first time from R. stricta.

Keywords